Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
about
Immune phenotypes predict survival in patients with glioblastoma multiforme.Immunosuppressive mechanisms in glioblastoma.Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model.A Cancer Research UK First Time in Human Phase I Trial of IMA950 (Novel Multipeptide Therapeutic Vaccine) in Patients with Newly Diagnosed GlioblastomaAnalysis of the intricate relationship between chronic inflammation and cancer.Glioblastoma-synthesized G-CSF and GM-CSF contribute to growth and immunosuppression: Potential therapeutic benefit from dapsone, fenofibrate, and ribavirin.Immune infiltration of tumor microenvironment following immunotherapy for glioblastoma multiforme.Cyclooxygenase-2 in glioblastoma multiforme.The interplay between metabolic remodeling and immune regulation in glioblastoma.Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen.Proliferative and Invasive Effects of Progesterone-Induced Blocking Factor in Human Glioblastoma Cells.Enhanced antitumor efficacy of biocompatible magnetosomes for the magnetic hyperthermia treatment of glioblastoma.The CD169 sialoadhesin molecule mediates cytotoxic T-cell responses to tumour apoptotic vesicles.
P2860
Q36120388-0D74F77C-81E3-428E-9955-9CA2CFB1247AQ36224048-20099320-316D-432E-B964-AAEBAF67E8E7Q36416387-DBE77055-39B8-40DF-B362-E1BD6786D0A8Q37262109-59D2BDB4-F8D4-488F-9700-11F7C8D01163Q38458724-F1899352-9D75-4795-A142-D6BEAE0E2286Q38811369-6B3C06A2-21DA-482B-B9C7-E643B2850923Q38864816-EAD98103-A885-497D-A6C1-1CB2620D0141Q38969912-CB7BA187-E3FD-4860-BB0F-0AF2A606BBC1Q39328710-ADC61EA3-C923-40A2-80E0-3A9F5BC274D8Q41809872-07A6CAF3-0C15-4A89-8088-5695DB5B6F7EQ42020080-52FE15E6-C92D-4659-93F1-8DCDADF59154Q44167533-8024ADB9-1B9B-466C-8E7A-83F2DF0EEEBAQ53250751-29171822-DCCF-4B73-A134-726F7888FFF4
P2860
Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
@en
type
label
Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
@en
prefLabel
Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
@en
P2093
P2860
P356
P1476
Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells.
@en
P2093
Astrid Authier
Kate W R Broadley
Kathryn J Farrand
Lindsay R Ancelet
Martin K Hunn
Sarrabeth Stone
P2860
P304
P356
10.1002/IJC.29309
P577
2014-11-12T00:00:00Z